MADRIGAL PHARMACEUTICALS INC's ticker is MDGL and the CUSIP is 558868105. A total of 135 filers reported holding MADRIGAL PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.42 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $785 | -99.8% | 3,240 | -32.2% | 0.08% | +52.9% |
Q4 2021 | $405,000 | -44.6% | 4,780 | -47.8% | 0.05% | -31.1% |
Q3 2021 | $731,000 | +50.1% | 9,156 | +83.0% | 0.07% | +34.5% |
Q2 2021 | $487,000 | +31.3% | 5,003 | +50.1% | 0.06% | -9.8% |
Q4 2020 | $371,000 | -66.7% | 3,334 | -72.8% | 0.06% | -53.1% |
Q4 2019 | $1,115,000 | +251.7% | 12,241 | +232.9% | 0.13% | +202.3% |
Q3 2019 | $317,000 | -33.4% | 3,677 | +116.0% | 0.04% | +79.2% |
Q2 2018 | $476,000 | – | 1,702 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
HealthCor Management, L.P. | 902,601 | $100,342,000 | 3.87% |
L1 Capital Pty Ltd | 113,464 | $12,608,000 | 2.35% |
Avoro Capital Advisors LLC | 1,225,000 | $136,183,000 | 2.34% |
Tao Capital Management LP | 51,396 | $5,714,000 | 1.40% |
ARMISTICE CAPITAL, LLC | 316,000 | $35,130,000 | 1.20% |
ACUTA CAPITAL PARTNERS, LLC | 32,500 | $3,613,000 | 0.98% |
Capital Impact Advisors, LLC | 24,351 | $2,707,000 | 0.66% |
Baker Brothers Advisors | 1,499,213 | $166,668,000 | 0.63% |
Rock Springs Capital Management LP | 256,768 | $28,545,000 | 0.60% |
SHIKIAR ASSET MANAGEMENT INC | 12,000 | $1,334,000 | 0.48% |